CytoDyn Inc. Quarterly Depreciation in USD from Q3 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CytoDyn Inc. quarterly/annual Depreciation history and growth rate from Q3 2023 to Q1 2025.
  • CytoDyn Inc. Depreciation for the quarter ending February 28, 2025 was $5K, a 28.6% decline year-over-year.
  • CytoDyn Inc. Depreciation for the twelve months ending February 28, 2025 was $18K.
  • CytoDyn Inc. annual Depreciation for 2023 was $29K, a 32.6% decline from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $18K $5K -$2K -28.6% Dec 1, 2024 Feb 28, 2025 10-Q 2025-04-14
Q4 2024 $20K $4K -$4K -50% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-14
Q3 2024 $24K $5K -$5K -50% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $29K $4K Mar 1, 2024 May 31, 2024 10-K 2024-08-15
Q1 2024 $7K Dec 1, 2023 Feb 29, 2024 10-Q 2025-04-14
Q4 2023 $8K Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-14
Q3 2023 $10K Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.